RxDoctor Payments Data

Karen Jones

Adult Health · Wildwood, FLNPI 1619182722

Payments from drug & device makers

$5,768in general payments, 2019–2025

Across 244 payments — averaging $23.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$937
  • Novo Nordisk$750
  • AbbVie$528
  • Lilly USA, LLC$524
  • Pfizer$392
  • AstraZeneca$383
  • plus $2K from 24 others

What the payments were for

  • Consulting fees$80014%
  • Speaking & faculty fees$2003%
  • Food & beverage$4,73682%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,768 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$21,476
Medicare patients
156
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tresiba Flextouch U-100Insulin Degludec11$1,132
Levothyroxine Sodium44$972
Omeprazole27$550
Atorvastatin Calcium48$534
Rosuvastatin Calcium40$532
Gabapentin28$505
Lisinopril43$436
Pantoprazole Sodium34$381
Escitalopram Oxalate26$346
Amlodipine Besylate54$320
Valsartan15$296
Sertraline Hcl22$257
Metoprolol Succinate16$249
Potassium Chloride11$246
Losartan Potassium34$228

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$97244 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,237 adult health providers in Florida.

Other adult health in Wildwood

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →